UA
FLGT icon

Unison Advisors’s Fulgent Genetics FLGT Stock Holding History

Unison Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,757
Closed -$230K – 176
2025
Q4 		$230K Buy
+8,757
New +$227K 0.02% 177
2024
Q1 		– Sell
-8,757
Closed -$253K – 180
2023
Q4 		$253K Hold
8,757
– – 0.03% 175
2023
Q3 		$234K Hold
8,757
– – 0.03% 174
2023
Q2 		$324K Hold
8,757
– – 0.04% 167
2023
Q1 		$273K Hold
8,757
– – 0.03% 169
2022
Q4 		$261K Hold
8,757
– – 0.03% 171
2022
Q3 		$334K Buy
8,757
+2,140
+32% +$107K 0.06% 152
2022
Q2 		$361K Hold
6,617
– – 0.09% 128
2022
Q1 		$413K Buy
+6,617
New +$436K 0.1% 122

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Unison Advisors's FLGT Position: Q1 2026 in Review

Unison Advisors sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 8,757 shares — an estimated $230K sold.

Unison Advisors first reported a position in FLGT in Q1 2022 and held it in 9 quarters. The position peaked at $413K in Q1 2022. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Unison Advisors reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Unison Advisors sold 8,757 Fulgent Genetics shares in Q1 2026, an estimated $230K.
  • Unison Advisors first reported a position in Fulgent Genetics in Q1 2022 and held it in 9 quarters.
  • Unison Advisors's Fulgent Genetics position peaked at $413K in Q1 2022.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Unison Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.